We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SPRB market cap is 28.4M. The company's latest EPS is USD -1.1771 and P/E is -0.59.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.96M | 2.17M | 3.07M | 2.89M |
| Operating Income | -12.11M | -13.2M | -13.97M | -13.66M | -11.16M |
| Net Income | -11.14M | -12.79M | -12.82M | -12.35M | -9.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 10.09M |
| Operating Income | -13.11M | -29.42M | -42.07M | -47.28M | -51.99M |
| Net Income | -13.09M | -29.54M | -42.29M | -46.18M | -47.92M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 85.65M | 139.11M | 125.96M | 112.99M | 103.95M |
| Total Liabilities | 17.16M | 31.12M | 29.4M | 27.6M | 27.44M |
| Total Equity | 68.49M | 108M | 96.56M | 85.38M | 76.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.69M | 162.88M | 126.49M | 85.65M | 103.95M |
| Total Liabilities | 7.52M | 13.46M | 15.12M | 17.16M | 27.44M |
| Total Equity | -30.64M | 149.43M | 111.37M | 68.49M | 76.51M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41.68M | -11.79M | -9.8M | -22.07M | -33.28M |
| Investing | 23.69M | 10.48M | 32.48M | 46.48M | 55.78M |
| Financing | -241k | 50.53M | 50.1M | 49.69M | 49.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.62M | -27.52M | -35.88M | -41.68M | -33.28M |
| Investing | -4k | -74k | -79.17M | 23.69M | 55.78M |
| Financing | 12.43M | 181.04M | 643k | -241k | 49.14M |
| Market Cap | 28.4M |
| Price to Earnings Ratio | -0.59 |
| Price to Sales Ratio | 2.82 |
| Price to Cash Ratio | 0.3 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 40.71M |
| Average Volume (1 week) | 425.25k |
| Average Volume (1 Month) | 466.12k |
| 52 Week Change | -72.10% |
| 52 Week High | 5.95 |
| 52 Week Low | 0.6711 |
| Spread (Intraday) | 0 (0.7%) |
| Company Name | Spruce Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sprucebiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
